Winding, fitful path to weight loss drug Ozempic
Novo Nordisk A/S NVO announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) ...
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...
The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...
Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...
The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...
Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...
Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...